Impact of ruxolitinib treatment on the hemoglobin dynamics and the negative prognosis of anemia in patients with myelofibrosis

MeSH terms

• Anemia / diagnosis*
• Anemia / etiology
• Anemia / pathology
• Clinical Trials, Phase III as Topic / statistics & numerical data
• Female
• Hemoglobins / analysis
• Hemoglobins / drug effects*
• Humans
• Male
• Nitriles
• Organ Size / drug effects
• Primary Myelofibrosis / complications
• Primary Myelofibrosis / diagnosis*
• Primary Myelofibrosis / drug therapy*
• Primary Myelofibrosis / mortality
• Prognosis
• Pyrazoles / therapeutic use*
• Pyrimidines
• Randomized Controlled Trials as Topic / statistics & numerical data
• Spleen / drug effects
• Spleen / pathology
• Survival Analysis
• Treatment Outcome